IGF1 and cancer: Last, but not least, IGFBP-2 protein expression also has been significantly down-regulated in both OS cell line when exposed to DK1; this molecule serves as a carrier that binds to IGF and extends the IGF’s half-life in order to maintain the modulation, circulation, and concentration which essential for cancer development [57].